Source: European Medicines Agency (EU) Revision Year: 2020 Publisher: RIEMSER Pharma GmbH, An der Wiek 7, 17493, Greifswald-Insel Riems, Germany
Prialt 25 micrograms/ml solution for infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion (infusion). Clear, colourless solution. |
One ml solution contains 25 μg ziconotide (as acetate).
Each 20 ml vial contains 500 μg ziconotide (as acetate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ziconotide |
Ziconotide is a synthetic analogue of a ω-conopeptide, MVIIA, found in the venom of the Conus magus marine snail. It is an N-type calcium channel blocker (NCCB). In binding to these neuronal NCCs ziconotide inhibits the voltage sensitive calcium current into primary nociceptive afferents terminating in the superficial layers of the dorsal horn of the spinal cord. |
| List of Excipients |
|---|
|
Methionine |
Type I glass vials with butyl rubber stoppers coated with fluorinated polymer.
Each vial contains 20 ml solution for infusion.
One vial per carton.
RIEMSER Pharma GmbH, An der Wiek 7, 17493, Greifswald-Insel Riems, Germany
EU/1/04/302/004 – 20 ml solution for infusion
Date of first authorisation: 21 February 2005
Date of latest renewal: 18 September 2014
| Drug | Countries | |
|---|---|---|
| PRIALT | Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
